Pemphigus Vulgaris Market Report 2026

Pemphigus Vulgaris Market Overview

• Pemphigus Vulgaris market size has reached to $1.94 billion in 2025 • Expected to grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Rising Prevalence Of Autoimmune Diseases Driving The Growth Of The Market Due To Increasing Diagnosis And Demand For Advanced Therapies • Market Trend: Investment Solutions Enhancing Access To Pemphigus Vulgaris Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pemphigus Vulgaris Market?

Pemphigus vulgaris is a rare, autoimmune disorder that causes blistering and sores on the skin and mucous membranes, such as the mouth, throat, and genitals. It occurs when the immune system mistakenly attacks the proteins that hold skin cells together, forming painful blisters. These blisters can rupture easily, resulting in raw, open sores. Pemphigus vulgaris is a chronic condition and can be life-threatening if not treated effectively, typically with immunosuppressive medications to control the immune system's abnormal response. The main types of pemphigus vulgaris diagnosis and treatment are diagnosis and treatment. Pemphigus vulgaris is diagnosed through clinical evaluation, skin biopsy, and immunological tests to detect autoantibodies. It occurs in various population types, such as pediatrics, adults, and geriatrics, and is distributed by several distribution channels, including hospitals, pharmacies, retail pharmacies, and online pharmacies. It is used by various end-users, such as hospitals, specialty clinics, research institutes, and others.

What Is The Pemphigus Vulgaris Market Growth Forecast?

The pemphigus vulgaris market size is expected to see strong growth in the next few years. It will grow to $2.79 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to rising adoption of targeted immunotherapies, increasing use of biologics and monoclonal antibodies, expanding teledermatology and remote monitoring solutions, advancements in early detection diagnostic tools, growing patient awareness and support programs. Major trends in the forecast period include increasing use of ai for early diagnosis and prognosis prediction, growing adoption of genomics-based personalized therapies, integration of cloud and big data for patient data management, use of iot-enabled devices for remote patient monitoring, implementation of smart manufacturing in immunosuppressive drug production.

Global Pemphigus Vulgaris Market Segmentation

1) By Diagnosis And Treatment: Diagnosis, Treatment 2) By Population Type: Pediatric, Adults, Geriatric 3) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy 4) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments: 1) By Diagnosis: Clinical Examination, Skin Biopsy, Direct Immunofluorescence, Serological Tests, Polymerase Chain Reaction (PCR) 2) By Treatment: Pharmacological Therapy, Non-Pharmacological Therapy

What Is The Driver Of The Pemphigus Vulgaris Market?

The prevalence of autoimmune diseases is expected to propel the growth of the pemphigus vulgaris market going forward. Autoimmune diseases are a group of disorders in which the immune system mistakenly attacks and damages the body's healthy cells, tissues, or organs. The prevalence of autoimmune diseases is increasing due to genetic predisposition, environmental triggers, and lifestyle changes. Genetic factors play a significant role, as individuals with a family history of autoimmune diseases are more likely to develop them due to inherited immune system vulnerabilities. As autoimmune diseases become more common due to genetic predisposition, environmental triggers, and lifestyle changes, more individuals are being diagnosed with conditions like pemphigus vulgaris, driving the demand for advanced therapies. For instance, in January 2025, according to Mayo Clinic Health System, a US-based network of community-based medical facilities that provides comprehensive healthcare services, the global incidence and prevalence of autoimmune diseases are rising, with annual increases estimated at 19.1% and 12.5%, respectively. Therefore, the prevalence of autoimmune diseases is deriving the growth of the pemphigus vulgaris industry.

Key Players In The Global Pemphigus Vulgaris Market

Major companies operating in the pemphigus vulgaris market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Amgen Inc., Sanofi S.A, Biogen Inc., Genentech, Genmab A/S, argenx SE, Daewoong Pharmaceutical Co. Ltd., HanAll Biopharma Co. Ltd., Artiva Biotherapeutics, Cabaletta Bio Inc., SinoMab BioScience Limited, Topas Therapeutics GmbH, Principia Biopharma Inc., Serpin Pharma LLC, Syntimmune Inc., International Pemphigus & Pemphigoid Foundation

Global Pemphigus Vulgaris Market Trends and Insights

Major companies operating in the pemphigus vulgaris market are focusing on investment solutions to improve treatment efficacy and expand therapeutic options. Investment solutions involve financial strategies and resources allocated to treatment development, research, and market introduction. For instance, in January 2023, Patient Access Network Foundation (PAN) Foundation, a US-based non-profit organization, launched a financial assistance program to provide up to $6,600 per year for eligible patients with pemphigus vulgaris to cover deductibles, copays, and coinsurance costs. To qualify for financial assistance, patients must undergo treatment for pemphigus vulgaris, have Medicare health insurance covering the necessary medications, and have an income at or below 400% of the federal poverty level. The PAN Foundation also offers transportation assistance and connects patients with support organizations.

What Are Latest Mergers And Acquisitions In The Pemphigus Vulgaris Market?

In December 2023, PAN Foundation, a US-based non-profit organization, partnered with the International Pemphigus & Pemphigoid Foundation to help people with pemphigus vulgaris. This partnership allows the PAN Foundation to provide up to $6,600 to eligible patients with pemphigus vulgaris and access to educational resources and support services, aiming to reduce the financial burden of treatment and improve their quality of life. International Pemphigus and Pemphigoid Foundation is a US-based non-profit organization that provides solutions for pemphigus vulgaris patients.

Regional Outlook

North America was the largest region in the pemphigus vulgaris market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pemphigus Vulgaris Market?

The pemphigus vulgaris market consists of revenues earned by entities by providing services such as physical therapy, palliative care, patient support groups, psychological support and counseling, and immunosuppressive therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The pemphigus vulgaris market includes sales of skin biopsy kits and serological test kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pemphigus Vulgaris Market Report 2026?

The pemphigus vulgaris market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pemphigus vulgaris industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.